Search results
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 12 hours agoCastle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript May 4, 2024 Castle...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 3 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
The long, frustrating wait for better sunscreens in America
NBC News via Yahoo News· 1 day agoThe FDA's ability to approve the chemical filters in sunscreens that are sold in other countries is...
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies - Cell...
Nature· 4 days agoForkhead box protein M1 (FOXM1) is often overexpressed in human cancers and strongly associated with therapy resistance and less good patient survival. The chemotherapy options for patients ...
1 in 3 Canadians think dangers of sun exposure are exaggerated: What to know about skin cancer risk,...
Yahoo Canada Style· 4 days ago"UVB rays are the main cause of sunburns and play a key role in the development of skin cancers,...
West Allis Hale girls soccer embodies 'never quit' attitude of assistant coach
Milwaukee Journal Sentinel via Yahoo Sports· 2 days agoI mean they're just...I get a couple hours each day." Huskies raise funds for 'Strain for the Brain'...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 3 days agoModerna is co-developing mRNA-4157 with Merck. Since the onset of 2024, the companies have initiated...
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoModerna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats...
ILD Not Increased With MTX in Patients With Dermatomyositis
Medscape· 4 days agoTreatment with methotrexate was not associated with an increased risk for interstitial lung disease...
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Zacks via Yahoo Finance· 4 days agoZanzalintinib, a third-generation tyrosine kinase inhibitor (TKI), is being evaluated in three...